Our Resources

The Excellerate team has made significant contributions to analytical pharmacology, particularly in the field of binding and signalling kinetics.

Here you can access useful fact sheets from the team, as well as publications, presentations and other useful content.

Publications

22 April, 2026

Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data; 2016

Lisa A Stott, David A Hall, Nicholas D Holliday
Read Paper
22 April, 2026

Discovery, Characterization, and Structure-Based Optimization of Small-Molecule in Vitro and in Vivo Probes for Human DNA Polymerase Theta; 2022

Martin L. Stockley et al. Excellerate contributing authors: Nicholas D. Holliday, Julija Sirina, Viral Patel
Read Paper
22 April, 2026

High-throughput kinetics in drug discovery; 2024

Maria Filipa Pinto, Julija Sirina, Nicholas D Holliday, Claire L McWhirter
Read Paper
22 April, 2026

Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2; 2023

Bianca Maria Casella, James P. Farmer, Desislava N. Nesheva, Huw E. L. Williams, Steven J. Charlton, Nicholas D. Holliday, Charles A. Laughton, Shailesh N. Mistry
Read Paper
22 April, 2026

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity; 2025

Aikaterini Motso et al. Excellerate contributing authors: Leigh A. Stoddart, Nicholas D. Holliday
Read Paper
22 April, 2026

Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammation; 2025

Lisa Patel, Fatima Garcia-Raposo, Benjamin Moore, James Wood, Lily Morley, David Loczenski, Stephen A. Smith, Puneeta Nath, Nicholas Holliday, Sam Williams, Iain R. Greig, Paul Vink, Martyn L. Foster
Read Paper
22 April, 2026

An industrial perspective on ligand bias in GPCR drug discovery; 2025

James P. Farmer, James E. Mason, Nicholas D. Holliday, Stephen J. Briddon, Leigh A. Stoddart
Read Paper
11 January, 2025

Micro-pharmacokinetics: Qualifying local drug concentration at live cell membranes; 2018

Karolina Gherbi, Stephen J Briddon, Steven J Charlton
Read Paper
11 January, 2025

Airway remodeling disease: primary human structural cells and phenotypic and pathway assays to identify targets with potential to prevent or reverse remodeling; 2018

Elizabeth M Rosethorne, Steven J Charlton
Read Paper
11 January, 2025

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors; 2017

David A Sykes, Holly Moore, Lisa Stott, Nicholas Holliday, Jonathan A Javitch, J Robert Lane, Steven J Charton
Read Paper
11 January, 2025

GPCRs – Structure, Function and Drug Discovery; 2019

Chapter: “Kinetics of ligand binding and signalling”
Read Paper

Webinars

22 April, 2026

Kinetics in preclinical pharmacology – Nick Holliday, BMG spotlight; 2024 ELRIG

Watch Webinar
11 January, 2025

The kinetics of drug binding – Prof Steven Charlton; 2016, BMG Labtech

Watch Webinar
11 January, 2025

Putting the dynamics into compound profiling: using kinetic assays to shape drug discovery; 2024, SPT Labtech

Watch Webinar

Fact sheets

11 January, 2025

Kinetics Fast Track; 2018

Download

Posters

22 April, 2026

Kinetic phenotyping of monocyte-to-macrophage differentiation using quantitative phase imaging ptychography; 2024

James Wood, Benjamin J.R. Moore, Lily Morley, Meetal Jotangia, Richard Woolley, Martin Humphry, Nicholas D. Holliday
Download
22 April, 2026

Kinetic phenotyping of cellular morphology, proliferation and motility using quantitative phase imaging ptychography; 2022

Benjamin J.R. Moore, Fatima Garcia-Raposo, Jessica Rickman, Richard Woolley, Martin Humphry, Nicholas D. Holliday. Presented at ELRIG Drug Discovery
Download
22 April, 2026

A Luciferase Complementation Approach to Measure GRK2 Recruitment to GPCRs; 2022

Mohammed Azim Miah, Julija Sirina, Nicholas D Holliday, Leigh A Stoddart. Presented at ELRIG Drug Discovery
Download
22 April, 2026

Integrating Signaling Kinetics into GPCR Compound Profiling; 2022

Leigh A Stoddart, Julija Sirina, Nicola C Dijon, Nicholas D Holliday. Presented at ELRIG Drug Discovery
Download
11 January, 2025

Antagonist binding kinetics at the human D1 dopamine receptor determined by HTRF assay; 2019

Kathy Sengmany, Ka-Wing Wong, Steven J Charlton, Nicholas Holliday. Presented at ELRIG Drug Discovery and the British Pharmacology Society
Download

Get in touch with the Excellerate team today to speak to one of our expert scientists

Contact Us
Location
Excellerate Biosciences Ltd
21 The Triangle
NG2 Business Park
Nottingham
NG2 1AE

Company Number: 10228159

VAT Number: GB 248960957

UK BioIndustry Association
Science Exchange
Cyber Essentials Certified
© 2026, Excellerate Bioscience Ltd. All Rights Reserved.
Manage Cookie Preferences Cookies & Privacy Policy